ABSTRACT
Introduction
Hepatocellular carcinoma (HCC) is a subtype of primary liver cancer and a major cause of death. Although miRNA plays an important role in hepatocellular carcinoma, the specific regulatory network remains unclear. Therefore, this paper comprehensively describes the miRNA-related signaling pathways in HCC and the possible interactions among different signaling pathways. The aim is to lay the foundation for the discovery of new molecular targets and multi-target therapy.
Areas covered
Based on miRNA, HCC, and signaling pathways, the literature was searched on Web of Science and PubMed. Then, common targets between different signaling pathways were found from KEGG database, and possible cross-regulation mechanisms were further studied. In this review, we elaborated from two aspects, respectively, laying a foundation for studying the regulatory mechanism and potential targets of miRNA in HCC.
Expert opinion
Non-coding RNAs have become notable molecules in cancer research in recent years, and many types of targeted drugs have emerged. From the outset, molecular targets and signal pathways are interlinked, which suggests that signal pathways and regulatory networks should be concerned in basic research, which also provides a strong direction for future mechanism research.
Article highlights
HCC is the main cause of death in liver cancer. Currently, the combination of chemotherapy and targeted therapy has been well applied.
Finding suitable targets is the key in targeted therapy, and non-coding RNAs such as miRNA have been widely studied as new molecular targets.
This review summarizes the specific molecular mechanisms of miRNAs and common signaling pathways in hepatocellular carcinoma and mediates signaling pathway activation by regulating key proteins and kinases.
The division in this paper focuses on different signaling pathways rather than phenotypes that have been reported in the literature.
The interaction between different signal pathways is summarized.
Declaration of interest
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Reviewer disclosures
Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.